France · Delayed Price · Currency is EUR AXA SA Earnings Call Transcripts
Fiscal Year 2026
-
Strong 2025 results and positive outlook were highlighted, with a focus on organic growth, AI-driven efficiency, and disciplined capital management. Retail and commercial lines are positioned for margin expansion, while AI is already improving loss ratios and productivity. Life business momentum is building, with further strategic updates expected in September.
Fiscal Year 2025
-
Record 2025 results with 6% premium growth, 26% net income rise, and 8% EPS increase, driven by strong performance across all segments, robust solvency, and strategic investments in AI and digital distribution. Confident outlook for 2026 at the high end of EPS growth targets.
-
Record 2025 results with 6% revenue and 8% EPS growth, strong capital position, and robust performance across all segments. Outlook for 2026 remains confident, targeting top-end EPS growth, with continued focus on efficiency, AI, and disciplined capital management.
-
Revenues rose 7% to €89 billion, with strong growth in both P&C and Life & Health segments. Solvency II ratio improved to 222%, and the group expects to deliver UEPS growth at the top end of its 6%-8% target. Moody’s upgraded the rating to Aa2.
-
Strong organic growth and margin improvements were achieved across all business lines, with disciplined cycle management and strategic investments in data, AI, and distribution. The group is on track to meet its plan targets, focusing on further growth in life, savings, and health, while maintaining robust capital management and risk discipline.
-
Strong organic growth with top line up 7% and underlying EPS up 8% year-over-year, supported by robust P&C and Life & Health performance and a 220% Solvency II ratio. Strategic acquisition of Prima and ongoing investments in technology and distribution underpin future growth.
-
Strong first half with 7% revenue growth and 6% higher underlying earnings, driven by all business lines and regions. Solvency II ratio rose to 220%, and strategic acquisitions like Prima in Italy strengthen core markets. Net income dipped 2% due to currency effects.
-
Q1 2025 saw 7% revenue growth to €37B, strong performance across all segments, and a robust 213% Solvency II ratio. P&C, life, and health all grew, with positive net flows and margin expansion, while asset management revenues rose 8% despite outflows.
-
The meeting celebrated 40 years of growth, reporting record revenues, strong earnings, and robust shareholder returns. Strategic priorities included digital transformation, AI, inclusive insurance, and climate action. All 29 resolutions were approved, and the Board reaffirmed its commitment to responsible governance and sustainable growth.
Fiscal Year 2024
-
Delivered 8% revenue and EPS growth, with record profits and strong performance across all segments. Announced a 9% dividend increase, €1.2B share buyback, and maintained a robust 216% solvency ratio. Confident in achieving plan targets, with continued margin and earnings growth expected.
-
Revenues grew 7% year-over-year, with strong performance in P&C and Life & Health, and a robust solvency ratio of 221%. Pricing remains favorable, supporting margin improvement, and 2024 EPS growth is expected to meet the 6%-8% target.
-
A major transformation has led to a simpler, balanced business model with strong capital discipline and ambitious growth targets. Proactive pricing, portfolio shifts, and operational improvements drive performance across P&C, life, and health, while robust cash and risk management underpin shareholder returns.
-
Organic growth reached 7% year-over-year, with strong performance across all business lines and geographies. The sale of AXA Investment Managers to BNP for €5.4 billion and the acquisition of Nobis Group in Italy mark significant strategic moves, while robust capital generation supports a 227% Solvency II ratio.